These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25865265)

  • 1. Plant-based production of two chimeric monoclonal IgG antibodies directed against immunodominant epitopes of Vibrio cholerae lipopolysaccharide.
    Levinson KJ; Giffen SR; Pauly MH; Kim DH; Bohorov O; Bohorova N; Whaley KJ; Zeitlin L; Mantis NJ
    J Immunol Methods; 2015 Jul; 422():111-7. PubMed ID: 25865265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the antigenic determinants of the lipopolysaccharides of Vibrio cholerae O:1, serotypes Ogawa and Inaba.
    Wang J; Villeneuve S; Zhang J; Lei P; Miller CE; Lafaye P; Nato F; Szu SC; Karpas A; Bystricky S; Robbins JB; Kovác P; Fournier JM; Glaudemans CP
    J Biol Chem; 1998 Jan; 273(5):2777-83. PubMed ID: 9446585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunochemical characterization of an Ogawa-Inaba common antigenic determinant of Vibrio cholerae O1.
    Villeneuve S; Boutonnier A; Mulard LA; Fournier JM
    Microbiology (Reading); 1999 Sep; 145 ( Pt 9)():2477-2484. PubMed ID: 10517600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Immunoglobulin Isotype and Epitope on the Functional Properties of
    Kauffman RC; Adekunle O; Yu H; Cho A; Nyhoff LE; Kelly M; Harris JB; Bhuiyan TR; Qadri F; Calderwood SB; Charles RC; Ryan ET; Kong J; Wrammert J
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879588
    [No Abstract]   [Full Text] [Related]  

  • 5. A monoclonal antibody that targets the conserved core/lipid A region of lipopolysaccharide affects motility and reduces intestinal colonization of both classical and El Tor Vibrio cholerae biotypes.
    Levinson KJ; Baranova DE; Mantis NJ
    Vaccine; 2016 Nov; 34(48):5833-5836. PubMed ID: 27773473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a novel protective monoclonal antibody that recognizes an epitope common to Vibrio cholerae Ogawa and Inaba serotypes.
    Dharmasena MN; Krebs SJ; Taylor RK
    Microbiology (Reading); 2009 Jul; 155(Pt 7):2353-2364. PubMed ID: 19389772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and Characterization of Monoclonal Antibodies to the Ogawa Lipopolysaccharide of
    Kim D; Hong J; Choi Y; Han J; Kim S; Jo G; Yoon JY; Chae H; Yoon H; Lee C; Hong HJ
    J Microbiol Biotechnol; 2020 Nov; 30(11):1760-1768. PubMed ID: 32876069
    [No Abstract]   [Full Text] [Related]  

  • 8. Rapid effects of a protective O-polysaccharide-specific monoclonal IgA on Vibrio cholerae agglutination, motility, and surface morphology.
    Levinson KJ; De Jesus M; Mantis NJ
    Infect Immun; 2015 Apr; 83(4):1674-83. PubMed ID: 25667263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-Cell Analysis of the Plasmablast Response to Vibrio cholerae Demonstrates Expansion of Cross-Reactive Memory B Cells.
    Kauffman RC; Bhuiyan TR; Nakajima R; Mayo-Smith LM; Rashu R; Hoq MR; Chowdhury F; Khan AI; Rahman A; Bhaumik SK; Harris L; O'Neal JT; Trost JF; Alam NH; Jasinskas A; Dotsey E; Kelly M; Charles RC; Xu P; Kováč P; Calderwood SB; Ryan ET; Felgner PL; Qadri F; Wrammert J; Harris JB
    mBio; 2016 Dec; 7(6):. PubMed ID: 27999163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Vibrio cholerae with monoclonal antibodies specific for serovar O1 lipopolysaccharide.
    Adams LB; Henk MC; Siebeling RJ
    J Clin Microbiol; 1988 Sep; 26(9):1801-9. PubMed ID: 3053778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humans Surviving Cholera Develop Antibodies against Vibrio cholerae O-Specific Polysaccharide That Inhibit Pathogen Motility.
    Charles RC; Kelly M; Tam JM; Akter A; Hossain M; Islam K; Biswas R; Kamruzzaman M; Chowdhury F; Khan AI; Leung DT; Weil A; LaRocque RC; Bhuiyan TR; Rahman A; Mayo-Smith LM; Becker RL; Vyas JM; Faherty CS; Nickerson KP; Giffen S; Ritter AS; Waldor MK; Xu P; Kováč P; Calderwood SB; Kauffman RC; Wrammert J; Qadri F; Harris JB; Ryan ET
    mBio; 2020 Nov; 11(6):. PubMed ID: 33203761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional profiling of Vibrio cholerae O1 following exposure to human anti- lipopolysaccharide monoclonal antibodies.
    Baranova DE; Willsey GG; Levinson KJ; Smith C; Wade J; Mantis NJ
    Pathog Dis; 2020 Jun; 78(4):. PubMed ID: 32589220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different types of monoclonal antibodies to Ogawa-specific and group-specific antigens of Vibrio cholerae O1.
    Ito T; Yokota T
    J Clin Microbiol; 1987 Dec; 25(12):2289-95. PubMed ID: 2448333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid detection of Vibrio cholerae O:1 by motility inhibition and immunofluorescence with monoclonal antibodies.
    Gustafsson B; Holme T
    Eur J Clin Microbiol; 1985 Jun; 4(3):291-4. PubMed ID: 2410265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and immunogenicity of a bivalent cell-surface protein-polysaccharide conjugate of Vibrio cholerae.
    Kabir S
    J Med Microbiol; 1987 Feb; 23(1):9-18. PubMed ID: 3820275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharides of Escherichia coli K12 strains that express cloned genes for the Ogawa and Inaba antigens of Vibrio cholerae O1: identification of O-antigenic factors.
    Hisatsune K; Kondo S; Iguchi T; Ito T; Hiramatsu K
    Microbiol Immunol; 1996; 40(9):621-6. PubMed ID: 8908606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The binding of synthetic analogs of the upstream, terminal residue of the O-polysaccharides (O-PS) of Vibrio cholerae O:1 serotypes Ogawa and Inaba to two murine monoclonal antibodies (MAbs) specific for the Ogawa lipopolysaccharide (LPS).
    Liao X; Poirot E; Chang AH; Zhang X; Zhang J; Nato F; Fournier JM; Kovác P; Glaudemans CP
    Carbohydr Res; 2002 Nov; 337(24):2437-42. PubMed ID: 12493228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunity Provided by an Outer Membrane Vesicle Cholera Vaccine Is Due to O-Antigen-Specific Antibodies Inhibiting Bacterial Motility.
    Wang Z; Lazinski DW; Camilli A
    Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27795359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of a monoclonal antibody directed against an antigenic determinant common to Ogawa and Inaba serotypes of Vibrio cholerae O1.
    Ahmed F; André-Leroux G; Haouz A; Boutonnier A; Delepierre M; Qadri F; Nato F; Fournier JM; Alzari PM
    Proteins; 2008 Jan; 70(1):284-8. PubMed ID: 17876834
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthetic fragments of Vibrio cholerae O1 Inaba O-specific polysaccharide bound to a protein carrier are immunogenic in mice but do not induce protective antibodies.
    Meeks MD; Saksena R; Ma X; Wade TK; Taylor RK; Kovác P; Wade WF
    Infect Immun; 2004 Jul; 72(7):4090-101. PubMed ID: 15213154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.